India’s challenges in regulating unproven stem cell interventions: Recommendations to strengthen adverse event reporting

Perspectives in Clinical Research · Published 2026-07-25 · DOI 10.4103/picr.picr_352_25

Free full text

Authors (3)

Kavita Srivastava, Lily Srivastava, Tanvi Jain

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Srivastava, K., Srivastava, L., Jain, T. (2026). India’s challenges in regulating unproven stem cell interventions: Recommendations to strengthen adverse event reporting. Perspectives in Clinical Research. https://doi.org/10.4103/picr.picr_352_25

Related articles

• The Indian regulatory framework and the surge of unproven stem cell therapies—a call for diagnosis · Journal of Law and the Biosciences · 2025 · Cites or is cited by this article
• Knowledge, attitude, and practice of informed consent among medical undergraduates: A cross-sectional study · Perspectives in Clinical Research · 2026 · Same journal
• Qualitative research – Part 1 · Perspectives in Clinical Research · 2026 · Same journal
• Building bridges in decentralized clinical trials: A qualitative exploration of stakeholder collaboration and implementation strategies · Perspectives in Clinical Research · 2026 · Same journal
• Preventability, predictability, severity, and causality analysis of serious adverse events reported to the institute ethics committee of a tertiary health care center in central India: A retrospective study · Perspectives in Clinical Research · 2026 · Same journal
• Efficacy and safety of topical phenytoin cream in diabetic foot ulcers: A randomized, open-label, parallel, and proof-of-concept study · Perspectives in Clinical Research · 2025 · Same journal
• Beyond consent: Reframing ethical governance in genetic data reuse within clinical trials · Perspectives in Clinical Research · 2026 · Same journal
• Quality of life in tuberculosis patients: A comparative study of video-observed therapy and directly observed therapy · Perspectives in Clinical Research · 2025 · Same journal
• Use of digital healthcare technology in clinical research in the Indian setting: Opportunities and challenges · Perspectives in Clinical Research · 2026 · Same journal
• Ozenoxacin 1% versus mupirocin 2% for topical treatment of impetigo and other uncomplicated skin infections: A randomized controlled trial · Perspectives in Clinical Research · 2026 · Same journal